Hyperplasia of the lymphoepithelium of NALT in rats but not in mice upon 28-day exposure to 15ppm formaldehyde vapor

Experimental and Toxicologic Pathology

Volumn 63, Issue 1-2, 2011, Pages 25-32

  Frieke Kuper, C ^a   van Oostrum, Lidy ^a   Ma Hock, Lan ^b   Durrer, Stefan ^b   Woutersen, Ruud A ^a  

^a TNO   (Netherlands)

^b BASF SE   (Germany)

Author keywords

BrdU; Cervical lymph nodes; Hyperplasia; Lymphoepithelium; PCA

Indexed keywords

BROXURIDINE; EOSIN; FORMALDEHYDE; HEMATOXYLIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B6C3F1 MOUSE; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM; EPITHELIUM CELL; EPITHELIUM HYPERPLASIA; FEMALE; FISCHER 344 RAT; IMMUNOHISTOCHEMISTRY; INHALATION; LYMPH NODE; LYMPHOEPITHELIUM; LYMPHOID TISSUE; MALE; MICROSCOPY; MOUSE; MOUSE STRAIN; NASOPHARYNX ASSOCIATED LYMPHOID TISSUE; NASOPHARYNX ASSOCIATED LYMPHOID TISSUE HYPERPLASIA; NONHUMAN; PRINCIPAL COMPONENT ANALYSIS; RAT; STAINING; TISSUE SECTION; VAPOR;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, LYMPHATIC; ENVIRONMENTAL POLLUTANTS; FEMALE; FORMALDEHYDE; HYPERPLASIA; INHALATION EXPOSURE; LYMPH NODES; LYMPHOID TISSUE; MALE; MICE; MICE, INBRED STRAINS; NASOPHARYNX; RATS; RATS, INBRED F344; TIME FACTORS; VOLATILIZATION;

MUS; RATTUS;

EID: 78650172419     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2009.09.004     Document Type: Article

References (32)

1. Arts J.H.E., De Jong W.H., Van Triel J.J., Schijf M.A., Van Loveren H., Kuper C.F. The respiratory local lymph node assay as a tool to study respiratory sensitizers. Toxicological Sciences 2008, 106:423-4434.
2. Asanuma H., Hodson Thompson A., Iwasaki T., Sato Y., Inaba Y., Aizawa C., et al. Isolation and characterization of mouse nasal-associated lymphoid tissue. Journal of Immunological Methods 1997, 202:123-1131.
3. Chang J.C.F., Gross E.A., Swenberg J.A., Barrow C.S. Nasal cavity deposition, histopathology, and cell proliferation after single or repeated formaldehyde exposures in B6C9F1 mice and F-344 rats. Toxicology and Applied Pharmacology 1983, 68:161-1176.
4. Cogliano V.J., Grosse Y., Baan R.A., Straif K., Secretan M.B., Ghissassi F.E.l Meeting report: summary of IARC monographs on formaldehyde, 2-butoxy-ethanol, and 1-tert-butoxy-2-propanol. Environmental Health Perspectives 2005, 113:1205-11208.
5. Devoney D., Vandenberg J., Whalen J. Hypothesized mode of action for formaldehyde-induced lymphoid malignancies. Toxicological Sciences 2006, V.97(S1):893.
6. Haley P., Perry R., Ennulat D., Frame S., Johnson C., Lapointe J.M., et al. STP Position paper: best practice guideline for the routine pathology evaluation of the immune system. Toxicologic Pathology 2005, 33:404-4407.
7. Harrison P.T.C. An ethanol-acetic acid-formol saline fixative for the routine use with special application to the fixation of non-perfused rat lung. Laboratory Animals 1984, 18:325-3331.
8. Hoogerbrugge R., Willig S.J., Kistemaker P.G. Discriminant analysis by double stage principal component analysis. Analytical Chemistry 1983, 55:1710-11712.
9. IARC International Agency for Research on Cancer: formaldehyde, 2-butoxyethanol and 1-tert-butoxypropan-2-ol. Monographs on the Evaluation of Carcinogenic Risks to Humans 2006, Vol. 88. WHO, Lyon, p. 39-325.
10. ICICIS group investigators Report of validation study of assessment of direct immunotoxicity in the rat. Toxicology 1998, 125:183-201.
11. Jolliffe I.T. Principal Component Analysis 1986, Springer Verlag, New York.
12. Kerns W.D., Pavkov K.L., Dougphrio D.J., Gralla E.J., Swenberg J.A. Carcinogenicity of formaldehyde in rats and mice after long-term inhalation exposure. Cancer Research 1983, 43:4382-4392.
13. Kuper C.F., Harleman H., Richther-Reichhelm H., Vos J.G. Histopathologic approaches to detect changes indicative of immunotoxicity. Toxicologic Pathology 2000, 28:454-466.
14. Kuper C.F., Arts J.H.E., Feron V.J. Toxicity to nasal-associated lymphoid tissue. Toxicology Letters 2003, 140-141:281-285.
15. Kuper C.F. Histopathology of mucosa-associated lymphoid tissue. Toxicologic Pathology 2006, 34:609-615.
16. Maronpot R.R. A monograph on histomorphologic evaluation of lymphoid organs. Toxicologic Pathology 2006, 34-35.
17. Martens H., Naes T. Multivariate Calibration 1989, John Wiley & Sons, Chichester.
18. Massart D.L., Vandeginste B.G.M., Buydens L.M.C., De Jong S., Lewi P.J., Smeyers-Verbeke J. Handbook of Chemometrics and Qualimetrics: Part A 1997, Elsevier, Amsterdam.
19. Merrill R.M., Isakson R.T., Beck R.E. The association between allergies and cancer: what is currently known?. Annual Allergy Asthma Immunology 2007, 99:102-117.
20. Murrell W., Feron F., Wetzig A., Cameron N., Splatt K., Bellette B., et al. Multipotent stem cells from adult olfactory mucosa. Developmental Dynamics 2005, 233:496-515.
21. Pyatt D., Natelson E., Golden R. Is inhalation exposure to formaldehyde a biologically plausible cause of lymphohematopoietic malignancies?. Regulatory Toxicology and Pharmacology 2008, 51:119-133.
22. Söderberg K.C., Hagmar L., Schwartzbaum J., Feychting M. Allergic conditions and risk of hematological malignancies in adults: a cohort study. BMC Public Health 2004, 4:51-56.
23. Swenberg J.A., Gross E.A., Randall H.W., Barrow C.S. The effect of formaldehyde exposure on cytotoxicity and cell proliferation. Formaldehyde toxicology, epidemiology, mechanisms 1983, 225-236. Marcel Dekker Inc., New York and Basel. J.J. Clary, J.E. Gibson, R.S. Waritz (Eds.).
24. Swenberg J.A., Gross E.A., Randall H.W. Localization and quantitation of cell proliferation following exposure to nasal irritants. Toxicology of the nasal passages 1986, 291-300. Hemisphere Publishing Corporation, Washington/New York/London. C.S. Barrow (Ed.).
25. Tilney N.L. Patterns of lymphatic drainage in the adult laboratory rat. Journal of Anatomy 1971, 109:369-383.
26. Van den Broeck W., Derore A., Simoens P. Anatomy and nomenclature of murine lymph nodes: descriptive study and nomenclature standardization in BALB/cAnCrl mice. Journal Immunological Methods 2006, 312:12-19.
27. Vandeginste B.G.M., Massart D.L., Buydens L.M.C., De Jong S., Lewi P.J., Smeyers-Verbeke J. Handbook of chemometrics and qualimetrics: Part B 1998, Elsevier, Amsterdam.
28. Wiley J.A., Tighe M.P., Harmsen A.G. Upper respiratory tract resistance to influenza infection is not prevented by the absence of either nasal-associated lymphoid tissue or cervical lymph nodes. Journal Immunology 2005, 3186-3196.
29. Wolvers D.A.W., Roo C.J.J.C., Mebius R.E., Cammen M.J.F., Tirion F., Miltenburg A.M.M., et al. Intranasal induced immunological tolerance is determined by characteristics of the draining lymph nodes: studeis with OVA and human cartilage gp-39. Journal of Immunology 1999, 162:1994-1998.
30. Woutersen R.A., Van Garderen-Hoetmer A., Slootweg P.J., Feron V.J. Upper respiratory tract carcinogenesis in experimental animals and humans. Carcinogenesis 1994, 215-264. Raven Press Ltd., New York. M.P. Waalkes, J.M. Ward (Eds.).
31. Woutersen R.A., Slootweg P., Kuper C.F. (in press) Chronic tissue changes and carcinogenesis in experimental animals and humans. In: Morris JB, Shusterman DJ, editors. Toxicology of the nose and upper airways. New York: Informa Health Care USA Inc.
32. Zhang L., Steinmaus C., Eastmond D.A., Xianjun K.X., Smith M.T. Formaldehyde exposure and leukemia: a new meta-analysis and potential mechanisms. Mutation Research - Reviews in Mutation Research 2009, 681:150-168.